Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 464-468

  Wen, Yue Jin ^a   Ling, Min ^a   Lim, Seah H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Idiotypic protein; Immunogenicity; Myeloma; T cells

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN IDIOTYPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CROSS REACTION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN GENE; MULTIPLE MYELOMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

CELL DIVISION; CROSS REACTIONS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN IDIOTYPES; INTERFERON TYPE II; MULTIPLE MYELOMA; MYELOMA PROTEINS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031865444     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00592.x     Document Type: Article

References (10)

1. Campbell, M.J., Esserman, L., Byars, N.E., Allison, A.C. & Levy, R. (1990) Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. Journal of Immunology, 145, 1029-1036.
2. Campbell, M.J., Esserman, L. & Levy, R. (1988) Immunotherapy of established murine B cell lymphoma: combination of idiotype immunization and cyclophosphamide. Journal of Immunology, 141, 3227-3233.
3. Chouaih, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A. & Blay, J.Y. (1997) The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunology Today, 18, 493-497.
4. Kwak, L.W., Campbell, M.J., Czerwinski, D., Hart, S., Miller, R.A. & Levy, R. (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. New England Journal of Medicine, 327, 1209-1215.
5. Kwak, L.W., Taub, D.D., Duffey, P.L. Bensinger, W.I., Bryant, E.M., Reynolds, C.W. & Longo, D.L. (1995) Transfer of myeloma idiotypic-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016-1020.
6. Kwak, L.W., Young, H.A., Pennington, R.W. & Weeks, S.D. (1996) Vaccination with syngeneic lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony stimulating factors primes mice to a protective T-cell response. Proceedings of the National Academy of Sciences of the United States of America, 93, 10972-10978.
7. Lim, S.H., Wen, Y.J., Ling, M. & Bailey-Wood, R. (1997) Idiotypic protein (ID)-pulsed adherent PBMC-derived dendritic cells (DC) prime immune system in multiple myeloma. Blood, 90, (Suppl. 1) 358a.
8. Osterborg, A., Yi, Q., Bergenbrant, S., Holm, G., Lefvert, A. & Mellstedt, H. (1995) Idiotypic-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests. British Journal of Haematology, 89, 110-116.
9. Pollard, P., Owen, G. & Worwood, M. (1993) PCR-based immunogenotyping at the Ig heavy chain CDR3 locus: improvements in resolution. British Journal of Haematology, 84, 169-171.
10. Wen, Y.J. & Lim, S.H. (1997) T cells recognise the VII complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. European Journal of Immunology, 27, 1043-1047.